CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chengdu Kanghua Biological Prdcts Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chengdu Kanghua Biological Prdcts Co Ltd
#182 Beijing Road
Economic Technology Development Zone
Phone: +86 2884882755p:+86 2884882755 Chengdu, SIC  610100  China Ticker: 300841300841
Business Summary
Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine products. The Company's main products are Rabies Vaccine (human diploid cell) for Human Use, Freeze-dried and Group ACYW135 Meningococcal Polysaccharide Vaccine. The Company distributes its products in domestic market and to overseas markets.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ZhentaoWang 58 7/21/2023
President, Director HongboWu 54 8/21/2023 7/21/2023
Finance Director, Deputy General Manager, Secretary of the Board, Director WennianWu 39 8/21/2023 8/21/2023
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 672 (As of 12/31/2023)
Outstanding Shares: 129,946,899 (As of 9/30/2024)
Shareholders: 18,906
Stock Exchange: SHE
Fax Number: +86 2884846577


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024